INTRARENAL ARTERIAL DOPPLER IN EVALUATION OF TYPE 2 DIABETICS

Dr Bikash Kumar Singh, Dr ANV Prasad

Abstract


Our primary objective was to evaluate the renal volume in diabetic patients of more than one year of duration. We also
aimed to evaluate the renal resistive index in diabetic patients of more than one year of duration


Keywords


Renal volume, renal resistive index (R.I), Glomerular ltration rate (G.F.R), Proteinuria

Full Text:

PDF

References


Cortes P, Dumler F, Goldman J, Levin NW. Relationship between renal function and

metabolic alterations in early streptozocin-induced diabetes in rats. Diabetes 1987;36:80–87.

Seyer-Hansen K. Renal hypertrophy in experimental diabetes: some functional aspects. J Diabet Complications 1987; 1:7–10.

Seyer-Hansen K. Renal hypertrophy in streptozotocin-diabetic rats. ClinSciMol Med

Suppl 1976; 51:551–555.

Platt JF, Ellis JH, Rubin JM, DiPietro MA, Sedman AB. Intrarenal arterial Doppler

sonography in patients with nonobstructive renal disease: correlation of resistive index

with biopsy findings. AJR Am J Roentgenol 1990; 154:1223–1227.

Taniwaki H, Nishizawa Y, Kawagishi T, et al. Decrease in glomerular filtration rate in

Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care 1998; 21:1848–1855.

Kadziela J, Witkowski A, Januszewicz A, et al. Assessment of renal artery stenosis using both resting pressures ratio and fractional flow reserve: relationship toangiography and ultrasonography. Blood Press 2011; 20:211–217.

Lee HY, Grant EG. Sonography in renovascular hypertension. J Ultrasound Med

; 21:431–441.

Li JC, Yuan Y, Qin W, et al. Evaluation of the tardus-parvus pattern in patients with

atherosclerotic and nonatherosclerotic renal artery stenosis. J Ultrasound Med 2007;

:419–426.

Zabala L, Ullah S, Pierce CD, et al. Transesophageal Doppler measurement of renal

arterial blood flow velocities and indices in children. AnesthAnalg 2012; 114:1277–

Forsblom CM, Groop PH, Ekstrand A, et al. Predictors of progression from

normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 1998; 21:1932–

Murussi M, Baglio P, Gross JL, Silveiro SP. Risk factors for microalbuminuria and

macroalbuminuria in type 2 diabetic patients: a 9-year follow-up study. Diabetes Care

; 25:1101–1103.

De Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. Antibodies

against vascular endothelial growth factor improve early renal dysfunction in

experimentaldiabetes.J Am Soc Nephrol2001; 12:993–1000.

Yamamoto Y, Maeshima Y, Kitayama H, et al. Tumstatin peptide, an inhibitor ofangiogenesis, prevents glomerular hypertrophy in the early stage of diabetic

nephropathy. Diabetes 2004; 53:1831–1840.


Refbacks

  • There are currently no refbacks.